Levetiracetam Aristo

Levetiracetam, the active ingredient in Levetiracetam Aristo, is an antiepileptic presented as an oral tablet for oral use. It is prescribed to manage various seizure types in patients with epilepsy, including partial‑onset, generalized tonic‑clonic and myoclonic seizures. It is available in multiple strengths to allow individualized dosing.

GNH USA supplies Levetiracetam Aristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU quality standards and is manufactured under GMP conditions.

Levetiracetam is an antiepileptic drug used to control seizure activity in several epilepsy syndromes.

Partial‑onset seizures: reduces the frequency of focal seizures in adults and children. Generalized tonic‑clonic seizures: helps prevent convulsive episodes in patients with generalized epilepsy. Myoclonic seizures: decreases myoclonic jerks in juvenile myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Fatigue or somnolence - Dizziness or vertigo - Headache - Irritability or mood changes - Nausea or abdominal discomfort - Nasal congestion

Serious or Rare Side Effects: - Severe allergic reactions (e.g., Stevens‑Johnson syndrome) - Suicidal thoughts or major depression - Blood dyscrasias such as leukopenia or thrombocytopenia - Acute psychosis or severe agitation - Hepatic dysfunction or elevated liver enzymes

When prescribing Levetiracetam, clinicians should consider several safety considerations.

Renal impairment: adjust dose based on creatinine clearance. History of psychiatric disorders: monitor for mood changes or suicidal thoughts. Concomitant CNS depressants: assess for additive sedation. Pregnancy: weigh benefits against potential risks; data are limited. Store at room temperature: keep in original container, protect from moisture and heat.

Levetiracetam has a relatively low interaction profile, but certain drug combinations require attention.

Major Interactions (Avoid): - Carbamazepine, phenytoin, phenobarbital: enzyme inducers that may markedly reduce levetiracetam plasma concentrations. - Rifampicin: strong inducer that can lower levetiracetam levels.

Moderate Interactions (Monitor Closely): - Alcohol: may increase central nervous system depression. - Other antiepileptics (e.g., valproate): may require monitoring of seizure control. - Renal‑clearing drugs (e.g., aminoglycosides): monitor renal function.